US
Europe

 

US
Europe

 

historymanagementboard of directors investors

press releasespress coverageelectronic press kit

media

  BOARD OF DIRECTORS

Axel Bolte
Investment Advisor, HBM Partners

Paul Chaney
Independent

Thomas Dyrberg, M.D., Ph.D.
Partner, Novo A/S

Lutz Giebel, Ph.D.
Managing Partner, SV Life Sciences

David R. Guyer, M.D.
Partner, SV Life Sciences
 
David Schnell, M.D.
Managing Director, Prospect Venture Partners

 

   
  © 2009 Lux Biosciences, Inc. All rights reserved. Web Terms Deutsch Enlarged Text
   
   

 

LUVENIQ™LX214LX212proprietary technologiespipeline

uveitisdry eye syndromeage-related macular degeneration

indicationstechnologies

aboutophthalmicproducts &partnersnews &careerscontact us